Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease

Journal of Microbiology, Immunology and Infection

Atsuko Hata¹  Kazufumi Takamatsu²  Satoshi Marumo²  Motonari Fukui² 

[1] Department of Pediatrics, Tazuke Kofukai Medical Research Institute Kitano Hospital, Japan;Department of Respiratory Medicine, Tazuke Kofukai Medical Research Institute Kitano Hospital, Japan;

关键词: Aging;    Antiviral drugs;    Geriatrics;    Gerontology;    High-risk patient;    Neuraminidase inhibitor;   

DOI  :  10.1016/j.jmii.2016.11.006

来源: DOAJ

【 摘 要 】

We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to normal temperatures was 31.5 h (95% CI: 22.4–40.6). Results confirm intravenous peramivir's usefulness.

【 授权许可】

Unknown